BarryAlanSchechterMD

Ophthalmology • Boynton Beach, FL

Cataract Related, Retinal Disease

Physician

Join to view full profile

Dr. Schechter is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schechter's full profile

Already have an account?

Office
1717 W Woolbright Rd
Boynton Beach, FL 33426
Phone+1 561-737-5500

Fax+1 561-737-7055

Education & Training

University of Texas Health Science Center at HoustonResidency, Ophthalmology, 1992 - 1993
SUNY Downstate Health Sciences UniversityResidency, Ophthalmology, 1989 - 1992
Icahn School of Medicine at Mount Sinai/Beth IsraelInternship, Internal Medicine, 1988 - 1989
State University of New York Downstate Medical Center College of MedicineClass of 1988

Certifications & Licensure

FL State Medical License 1992 - 2026
TX State Medical License 1992 - 1993
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Top MD Consumers Checkbook
Fellow (FAAO) American Academy of Ophthalmology

Clinical Trials

Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia
Completed
Phase 4
Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase Start of enrollment: 2007 Aug 01
Completed
Phase 4
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear and Systane for the Treatment of Dry Eye Signs, Symptoms and Visual Quality Start of enrollment: 2008 Feb 01
Completed
Phase 4
Prospective Evaluation of Near and Intermediate Visual Outcomes With Monofocal Intraocular Lenses: The Mast Study Start of enrollment: 2010 Aug 01
Unknown status
Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease Start of enrollment: 2016 Jun 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
Optimization of the Ocular Surface Through Treatment of Ocular Surface Disease Before Ophthalmic Surgery: A Narrative Review.
Barry Schechter, Francis Mah
Ophthalmology and Therapy. 2022-06-01
Effect of OTX-101 in Patients with Dry Eye Disease at Day 14 of Treatment: Ocular Surface Endpoint Results from the Phase 2b/3 Clinical Trial.
Barry A Schechter, Maitee Urbieta, Jason Bacharach, Melissa Toyos, Robert Smyth-Medina
Clinical Ophthalmology. 2022-01-01
4 citations
Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca.
John D. Sheppard, M.T. Bergmann, Barry A. Schechter, Jodi Luchs, Abayomi Ogundele
Clinical Ophthalmology. 2021-01-12

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow